VTVT - vTv Therapeutics GAAP EPS of -$0.04 August, 16 2022 03:00 AM vTv Therapeutics Inc. vTv Therapeutics press release ( NASDAQ: VTVT ): Q2 GAAP EPS of -$0.04. The Company’s cash position as of June 30, 2022, was $17.9M compared to $13.4M as of December 31, 2021. For further details see: vTv Therapeutics GAAP EPS of -$0.04